lobbying_activities: 3034820

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3034820	4f3764b6-44fc-44eb-9cb5-a4f0198b6366	Q2	JUUL LABS, INC.	401104897	JUUL LABS INC	2023	second_quarter	TOB	Risk-proportionate regulation for electronic delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 901, the Disposable ENDS Product Enforcement Act of 2023.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		500000	0	0	2023-07-20T17:25:55-04:00